Deutsche Boerse and the London Stock Exchange Group have submitted their $29 billion merger deal to European Union competition regulators ahead of a Sept. 28 deadline for a preliminary review.
The deal, which will create the world’s biggest exchange by revenue, is likely to face tough scrutiny because of the huge combined presence of the two companies in derivatives clearing.
The European Commission’s antitrust department, whose approval is needed for the deal to proceed, has set a provisional deadline of Sept. 28 for its preliminary review.
“We believe the merger will create significant value for our customers and shareholders, and facilitate economic growth through the creation of a global markets infrastructure group, anchored in Europe,” the exchanges said on Thursday.
The LSE’s LCH.Clearnet is Europe’s main clearing house for euro-denominated swaps and that could be a concern for the EU competition enforcer. Analysts say the exchanges may have to offer major concessions such as selling overlapping businesses.
The exchanges expect the EU scrutiny to broaden into a full investigation of about five months. Belgium, Portugal and the Netherlands, trading locations of rival exchange Euronext, have already expressed concerns about the deal.
Full Content: Financial Times
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
FTC Chair Proposes 15% Staff Reduction Amid Budget Constraints
May 15, 2025 by
CPI
UK Urges Antitrust Watchdog to Prioritize Growth and Clarity in Business Regulation
May 15, 2025 by
CPI
Athletes File New Objections to NCAA’s $2.8 Billion Settlement Proposal
May 15, 2025 by
CPI
TikTok Charged by EU Over Alleged Breach of Digital Services Act
May 15, 2025 by
CPI
House Budget Bill’s Moratorium on State AI Laws Could Undo A Range of Tech Regs, Critics Say
May 14, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas